Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases.

Carcinogenesis 2013 Apr 3;34(4):828-34. Epub 2013 Jan 3.

INSERM/UMR S 938 - Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancers, Equipe Labellisée Ligue Contre le Cancer, Paris, France.

Microsatellite instability (MSI) due to mismatch repair (MMR) deficiency is reported in 5-10% of colorectal cancers (CRCs) complicating inflammatory bowel diseases (IBD). The molecular mechanisms underlying MMR deficiency may be different in IBD CRCs, and in sporadic and hereditary MSI tumors. Here, we hypothesize that overexpression of miR-155 and miR-21, two inflammation-related microRNAs that target core MMR proteins, may constitute a pre-neoplastic event for the development of MSI IBD CRCs. We studied miR-155 and miR-21 expression using real-time quantitative PCR in MSI (n = 10) and microsatellite stable (n = 10) IBD CRCs, and in MSI (n = 32) and microsatellite stable (n = 30) non-IBD CRCs. We also screened colonic samples from IBD patients without cancer (n = 18) and used healthy colonic mucosa as controls (n = 20). MiR-155 and miR-21 appeared significantly overexpressed not only in the colonic mucosa of IBD subjects without CRC but also in neoplastic tissues of IBD patients compared with non-IBD controls (P < 0.001). Importantly, in patients with IBD CRCs, miR-155 and miR-21 overexpression extended to the distant non-neoplastic mucosa (P < 0.001). Ratios of expressions in tumors versus matched distant mucosa revealed a nearly significant association between miR-155 overexpression and MSI in IBDs (P = 0.057). These results show a strong deregulation of both MMR-targeting microRNAs in IBD subjects with or without cancer. MiR-155 overexpression being particularly associated to MSI IBD CRCs and extending to distant non-neoplastic mucosa, strongly suggests that a pre-neoplastic miR-155 field defect may promote MSI-driven transformation of the colonic mucosa. The detection and monitoring of miR-155 field defect may, therefore, have implications for the prevention and treatment of MSI IBD CRCs.

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs408DOI Listing
April 2013
17 Reads

Publication Analysis

Top Keywords

ibd crcs
24
mir-155 mir-21
16
colonic mucosa
12
msi ibd
12
ibd
11
mir-155 field
8
msi
8
ibd subjects
8
ibd patients
8
mir-155 overexpression
8
distant non-neoplastic
8
non-neoplastic mucosa
8
mir-155
8
bowel diseases
8
crcs
8
mmr deficiency
8
microsatellite stable
8
field defect
8
mismatch repair
8
msi microsatellite
8

References

(Supplied by CrossRef)

Ekbom et al.
New England Journal of Medicine 1990

Gillen et al.
Gut 1994

Gillen et al.
Gut 1994

Rutter et al.
Gastroenterology 2004

Gastroenterology 2011

Schulmann et al.
Gastroenterology 2005

Svrcek et al.
Journal of Clinical Oncology 2007

Duval et al.
Cancer Research 2002

Hampel et al.
New England Journal of Medicine 2005

Truninger et al.
Gastroenterology 2005

Aaltonen et al.
Science 1993

Similar Publications